US Stock MarketDetailed Quotes
KRBP Kiromic BioPharma
- 0.910
- -0.220-19.47%
15min DelayTrading Nov 22 09:59 ET
1.41MMarket Cap-146P/E (TTM)
0.910High0.910Low166Volume0.910Open1.130Pre Close151.06Turnover0.01%Turnover RatioLossP/E (Static)1.55MShares3.78052wk High-0.15P/B1.05MFloat Cap0.18052wk Low--Dividend TTM1.15MShs Float555.000Historical High--Div YieldTTM0.00%Amplitude0.160Historical Low0.910Avg Price1Lot Size
Kiromic BioPharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -33.23%2.92M | 49.69%4.05M | 78.94%3.68M | 396.59%3.2M | 396.59%3.2M | 912.13%4.38M | -58.46%2.7M | -86.42%2.05M | -97.46%645.2K | -97.46%645.2K |
| -Cash and cash equivalents | -33.23%2.92M | 49.69%4.05M | 78.94%3.68M | 396.59%3.2M | 396.59%3.2M | 912.13%4.38M | -58.46%2.7M | -86.42%2.05M | -97.46%645.2K | -97.46%645.2K |
| Restricted cash | --132K | --131K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other current assets | -19.97%1.25M | -8.01%1.85M | 29.38%1.89M | 17.47%1.23M | 17.47%1.23M | -8.64%1.56M | 31.95%2.01M | -9.05%1.46M | -38.58%1.04M | -38.58%1.04M |
| Total current assets | -27.53%4.3M | 27.87%6.03M | 58.33%5.57M | 162.30%4.43M | 162.30%4.43M | 177.70%5.94M | -41.33%4.71M | -78.98%3.52M | -93.76%1.69M | -93.76%1.69M |
| Non current assets | ||||||||||
| Net PPE | -28.44%5.92M | -27.93%6.42M | -26.42%7.04M | -24.74%7.72M | -24.74%7.72M | -23.74%8.27M | -22.29%8.9M | 4.81%9.57M | 182.56%10.25M | 182.56%10.25M |
| -Gross PPE | -1.05%12.51M | -2.02%12.45M | -2.39%12.52M | -2.44%12.64M | -2.44%12.64M | -2.77%12.64M | -2.77%12.71M | 23.99%12.82M | 177.96%12.95M | 177.96%12.95M |
| -Accumulated depreciation | -50.88%-6.59M | -58.57%-6.04M | -68.24%-5.48M | -82.25%-4.92M | -82.25%-4.92M | -103.06%-4.37M | -135.89%-3.81M | -168.15%-3.26M | -161.78%-2.7M | -161.78%-2.7M |
| Other non current assets | -1.87%21K | -1.87%21K | -13.93%21K | -12.30%21.4K | -12.30%21.4K | -31.19%21.4K | -31.19%21.4K | -21.54%24.4K | -21.54%24.4K | -21.54%24.4K |
| Total non current assets | -28.37%5.94M | -27.87%6.44M | -26.39%7.06M | -24.71%7.74M | -24.71%7.74M | -23.76%8.3M | -22.32%8.92M | 4.72%9.59M | 180.83%10.28M | 180.83%10.28M |
| Total assets | -28.02%10.25M | -8.60%12.46M | -3.66%12.63M | 1.68%12.17M | 1.68%12.17M | 9.33%14.23M | -30.14%13.64M | -49.37%13.11M | -61.06%11.97M | -61.06%11.97M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | -60.14%1.69M | -69.86%2M | -75.47%2M | -70.77%2.14M | -70.77%2.14M | -34.60%4.25M | 59.03%6.62M | 254.03%8.15M | 230.04%7.31M | 230.04%7.31M |
| -accounts payable | -60.14%1.69M | -69.86%2M | -75.47%2M | -70.77%2.14M | -70.77%2.14M | -34.60%4.25M | 59.03%6.62M | 254.03%8.15M | 230.04%7.31M | 230.04%7.31M |
| Current accrued expenses | -20.14%2.01M | -53.91%1.33M | 420.50%3.31M | 673.63%2.75M | 673.63%2.75M | -30.09%2.52M | 471.95%2.88M | -14.32%636.5K | -24.00%355K | -24.00%355K |
| Current debt and capital lease obligation | 39.24%14.31M | 44.19%12.79M | 21.30%12.83M | 195.49%14.63M | 195.49%14.63M | 1,776.10%10.28M | 1,263.83%8.87M | 1,281.21%10.58M | 989.44%4.95M | 989.44%4.95M |
| -Current debt | 41.24%13.64M | 46.87%12.14M | 22.13%12.19M | 220.58%14M | 220.58%14M | --9.66M | 7,091.38%8.26M | 3,394.19%9.98M | 860.86%4.37M | 860.86%4.37M |
| -Current capital lease obligation | 8.10%670K | 7.75%656K | 7.50%642K | 7.97%631K | 7.97%631K | 13.14%619.8K | 13.67%608.8K | 24.34%597.2K | --584.4K | --584.4K |
| Current liabilities | 8.39%19.13M | -8.79%17.06M | -3.86%19.09M | 53.41%20.38M | 53.41%20.38M | 58.86%17.65M | 213.29%18.7M | 383.77%19.86M | 289.56%13.28M | 289.56%13.28M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | -62.35%404K | -53.15%577K | -46.20%747K | -79.56%911.5K | -79.56%911.5K | -34.02%1.07M | -30.42%1.23M | -20.52%1.39M | --4.46M | --4.46M |
| -Long term debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2.91M | --2.91M |
| -Long term capital lease obligation | -62.35%404K | -53.15%577K | -46.20%747K | -41.00%911.5K | -41.00%911.5K | -34.02%1.07M | -30.42%1.23M | -20.52%1.39M | --1.54M | --1.54M |
| Total non current liabilities | -62.35%404K | -53.15%577K | -46.20%747K | -79.56%911.5K | -79.56%911.5K | -34.02%1.07M | -30.42%1.23M | -20.76%1.39M | --4.46M | --4.46M |
| Total liabilities | 4.34%19.53M | -11.53%17.63M | -6.63%19.84M | 20.00%21.29M | 20.00%21.29M | 47.00%18.72M | 157.54%19.93M | 262.74%21.25M | 420.33%17.74M | 420.33%17.74M |
| Shareholders'equity | ||||||||||
| Share capital | -15.11%1K | -15.04%1K | 2.15%1K | 94.44%1.26K | 94.44%1.26K | -87.33%1.18K | -87.34%1.18K | -89.47%979 | 25.58%648 | 25.58%648 |
| -common stock | -14.97%1K | -14.97%1K | 2.15%1K | 94.14%1.26K | 94.14%1.26K | -87.35%1.18K | -87.35%1.18K | -89.47%979 | 25.58%648 | 25.58%648 |
| -Preferred stock | --0 | --0 | --0 | --2 | --2 | --2 | --1 | --0 | --0 | --0 |
| Retained earnings | -21.23%-143.3M | -19.17%-135.87M | -20.32%-129.05M | -20.55%-122.9M | -20.55%-122.9M | -24.58%-118.21M | -37.33%-114.01M | -43.79%-107.25M | -51.67%-101.95M | -51.67%-101.95M |
| Paid-in capital | 17.85%134.02M | 21.34%130.7M | 22.93%121.83M | 18.30%113.77M | 18.30%113.77M | 19.51%113.72M | 13.64%107.72M | 4.76%99.11M | 1.73%96.17M | 1.73%96.17M |
| Total stockholders'equity | -106.98%-9.29M | 17.87%-5.17M | 11.40%-7.21M | -57.94%-9.12M | -57.94%-9.12M | -1,679.51%-4.49M | -153.43%-6.29M | -140.64%-8.14M | -121.14%-5.77M | -121.14%-5.77M |
| Total equity | -106.98%-9.29M | 17.87%-5.17M | 11.40%-7.21M | -57.94%-9.12M | -57.94%-9.12M | -1,679.51%-4.49M | -153.43%-6.29M | -140.64%-8.14M | -121.14%-5.77M | -121.14%-5.77M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
